SPOTLIGHT -
Dr. Giaconne on the Lack of Funding for Rare Cancers Research
Giuseppe Giaccone, MD, PhD, highlights the difficulties with funding for research focused on rare cancers.
Read More
Dr. Giaccone on Investigational Agents in Thymic Cancers
Giuseppe Giaccone, MD, PhD, discusses recent data with investigational therapies for patients with thymic cancer.
Dr. Giaccone on the Challenge of Diagnosing Thymic Cancers
Giuseppe Giaconne, MD, PhD, discusses why thymic cancers can be difficult to classify histologically, so the actual incidence is unclear.
Drs Giaccone and He on Raising Awareness in Thymic Cancers
Giuseppe Giaconne, MD, PhD, and Yongfeng He, PhD, discuss how cancers of the thymus, a small organ located in the mediastinum above the heart, are uncommon and understudied.
Dr. Giaccone on Treatment Options in NSCLC
Giuseppe Giaccone, MD, PhD, discusses current treatment options in non–small cell lung cancer.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)